Mortgage Applications Slip 3.8% as Purchase Demand Stays
In the week ending June 12, 2026, mortgage applications slip 3.8% as purchase demand stays ahead of 2025, signaling a...
Which Funds Have Best Annual Risk Adjusted Returns
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articles
Dollar-Cost Averaging: Why Timing the Market Is a Losing Game
Market timing is tempting but risky. Dollar-Cost Averaging lets you invest steadily, reduce emotional decisions, and ...
KBR Stock Fallen This Past Year: Lone Peak Bets $24 Million on a Turnaround
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
AVDE’s 23.6% Annual Gain Signals Global Dividends Surge
Avantis International Equity ETF AVDE posted a 23.6% trailing-12-month gain, signaling durable income from global div...
Logan Paul Says Calling Defamation Claims Into Focus
Influencer clashes over defamation put a spotlight on money, risk, and what you should scrutinize before backing ever...
Best Warren Buffett Stocks to Buy with $300 Right Now
If you have only $300 to start investing, you can still build a Buffett-inspired portfolio. This guide shows five dur...
Cathie Wood Loading This GLP-1 Stock: What It Means for Investors
A high-profile investor move has eyes turning to a GLP-1 stock with big growth potential. Here’s what it means for ri...
Better Buy: Versus Nvidia Stock — a Practical Guide
AMD and Nvidia lead the AI GPU wave, but they aren’t identical bets. This guide breaks down how to compare them, with...
SCHB VTV: SCHB Targets Broad Market vs Value Tilt
SCHB and VTV offer low-cost ways to invest in U.S. stocks, but they serve different purposes. One captures the broad ...
Biggest Bargain Magnificent Seven Stocks to Watch Today
The Magnificent Seven have long led the market, but their valuations have cooled. Explore the three biggest bargain p...
Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Dyadic (DYAI) 2025 Earnings: Key Takeaways for Investors
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status